News
We recently published a list of Billionaire Israel Englander’s 10 Stock Picks with Huge Upside Potential. In this article, we are going to take a look at where IQVIA Holdings Inc. (NYSE:IQV) stands ...
IQVIA™ (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence ...
Luke Greenwalt, MBA, on the Current Market Conditions for New Drug Launches | Asembia's AXS25 Summit
The vice president and lead of IQVIA's Market Access Center of Excellence says fewer drugs are hitting the $100 million mark ...
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $227.67, ...
HSBC analyst Sidharth Sahoo downgraded Iqvia (IQV) to Hold from Buy with a price target of $160, down from $260. The firm adjusted ratings in ...
Shares of Centene Corp. advanced 3.09% to $59.47 Monday, on what proved to be an all-around positive trading session for the ...
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
The stock's rise snapped a four-day losing streak.
IQVIA named a front-runner in generative AI innovation by global industry research and analysis firm
IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, ...
Board Certified in Endocrinology, Diabetes, and Metabolism and Internal Medicine, Dr. Caveney leads IQVIA’s Obesity, ...
IQVIA named a front-runner in generative AI innovation by global industry research and analysis firm
IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, announced today that the global independent research and analysis firm ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results